Biochemical and quality of life responses to octreotide-LAR in acromegaly

Conclusion Oct-LAR therapy in acromegaly improved quality of life scores in parallel to biochemical markers, except in patients with severe headaches. The AcroQoL questionnaire is an additional tool to establish therapeutic effectivity.

http://link.springer.com/10.1007/s11102-013-0533-x

Source: Pituitary - November 6, 2014 Category: Endocrinology Source Type: research